Alzheimer's Research
To learn more about Alzheimer’s, memory loss and ongoing clinical trials in this area, visit our Alzheimer’s Disease Research page.
Learn MoreThe main goals of this study are to further determine whether the study drug donanemab is safe and effective in participants with Alzheimer's disease and to validate video scale assessments.
Participants must have gradual and progressive change in memory function reported by participants or informants for 6 months
Participants must have have MMSE score of 20 to 28 (inclusive) at baseline
Participants must have 18F flortaucipir PET scan (central read) criteria
Participants must have met 18F florbetapir PET scan (central read) criteria
Participants must have a study partner who will provide written informed consent to participate
Participants must not have contraindication to MRI or PET scans
Participants must not receive current treatment with immunoglobin G (IgG) therapy
To learn more about Alzheimer’s, memory loss and ongoing clinical trials in this area, visit our Alzheimer’s Disease Research page.
Learn MoreTo learn more about neurological disorders and ongoing clinical trials in the area, visit our Neurological Disorders Research page.
A clinical trial helps us learn if a new potential medicine or treatment works and how it works. Clinical trials are also called clinical research studies. To learn more about what to expect when taking part in a clinical trial, visit our Clinical Trial Information page.